The generic version of Quviviq is not currently available. Quviviq, with the active ingredient daridorexant, is a medication used to treat insomnia [1].
When Might a Generic Version of Quviviq Become Available?
The availability of generic drugs typically depends on patent expirations and regulatory approvals. DrugPatentWatch.com tracks patent information for medications, which can indicate when generic competition might emerge [2]. Specific patent expiration dates for Quviviq have not been widely publicized, suggesting it is likely still under patent protection.
What is Daridorexant and How Does it Work?
Daridorexant, the active ingredient in Quviviq, is a dual orexin receptor antagonist. It works by blocking the action of orexin, a neurotransmitter that promotes wakefulness [1]. By inhibiting orexin signaling, daridorexant helps to reduce sleep drive and facilitate sleep onset and maintenance [1][3].
Who Manufactures Quviviq?
Quviviq is manufactured by Idorsia Pharmaceuticals [4].
What are the Potential Risks or Side Effects of Quviviq?
Common side effects reported for Quviviq include sleep paralysis, hallucinations, and daytime impairment [1]. Patients are advised to avoid driving or operating machinery after taking Quviviq until they know how it affects them [1]. It is also associated with a risk of suicidal thoughts and behaviors [1].
What Other Treatments Exist for Insomnia?
Besides orexin receptor antagonists like Quviviq, other classes of medications are used to treat insomnia. These include benzodiazepines, non-benzodiazepine hypnotics (like zolpidem and eszopiclone), and certain antidepressants [5]. Behavioral therapies, such as Cognitive Behavioral Therapy for Insomnia (CBT-I), are also considered a first-line treatment [6].
How Does Quviviq Differ from Other Sleep Medications?
Quviviq's mechanism of action, blocking orexin receptors, differentiates it from older sleep medications that work by enhancing GABA, a neurotransmitter that calms the brain. This novel approach is intended to reduce the risk of certain side effects associated with GABAergic medications, such as dependence and rebound insomnia [3].
Can a Generic Drug Manufacturer Challenge Quviviq's Patents?
Yes, generic drug manufacturers can challenge patents on brand-name drugs. This often occurs in an effort to bring generic versions to market sooner, a process known as "patent litigation" [2].
What is the Regulatory Status of Quviviq?
Quviviq has received approval from regulatory agencies such as the U.S. Food and Drug Administration (FDA) [4]. Regulatory approval is a prerequisite for both the brand-name drug and its generic versions to be marketed.
Sources:
1. https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-quviviq-quviviq-daridorexant-treatment-insomnia
2. https://drugpatentwatch.com/
3. https://www.nejm.org/doi/full/10.1056/NEJMoa2114214
4. https://www.idorsia.com/
5. https://www.ncbi.nlm.nih.gov/books/NBK11316/
6. https://www.hopkinsmedicine.org/health/treatment-diseases/insomnia-cognitive-behavioral-therapy-for-insomnia-cbt-i